Back to Authors

Kantarci, Kejal

0000-0002-8001-2081

Mayo Clinic

Mayo Clinic

Citations 247

MRS in Mild Cognitive Impairment: Early Differentiation of Dementia with Lewy Bodies and Alzheimer's Disease
Ferman, Tanis J. , Smith, Glenn E. , Maroney‐Smith, Mandie, Spychalla, Anthony J., Jack, Clifford R. , Petersen, Ronald C. , Kantarci, Kejal , Maroney-Smith, Mandie, Zhang, Bing , Boeve, Bradley F. , Knopman, David S. , Jack, Clifford R , Kantarci, Kejal , Ferman, Tanis J

Journal of Neuroimaging | July 16, 2014 | Volume: 25 | Issue: 2 | Pages: 269-274

10.1111/jon.12138 Get It

ABSTRACTBACKGROUND AND PURPOSEMild cognitive impairment (MCI) precedes both Alzheimer's disease (AD) dementia and with Lewy bodies (DLB). We investigated proton magnetic resonance spectroscopy (MRS) characteristics of MCI patients who progressed to DLB compared to those who progressed to AD dementia or remained stable.METHODSConsecutive MCI patients who underwent single voxel MRS at baseline and progressed to DLB (n = 10) were identified during a median follow‐up period of 18 months. From the same cohort, we identified age‐ and sex‐matched MCI patients who progressed to AD dementia (n = 27) or remained stable (n = 20) during a similar follow‐up period. This study was approved by the Institutional Review Board and informed consent was from every subject.RESULTSMCI patients who progressed to AD dementia were characterized by lower N‐acetylaspartate (NAA)/Cr ratio in the posterior cingulate voxel compared to those who progressed to DLB (P = .001). Decreased NAA/Cr in the posterior cingulate voxel differentiated MCI patients who progressed to DLB from those who progressed to AD with an area under the receiver operating characteristic curve of .85 (P < .001) on logistic regression analysis.CONCLUSIONSMRS may be useful in differentiating MCI patients with prodromal AD dementia from those with prodromal DLB for early disease‐specific interventions.
Association of hypometabolism and amyloid levels in aging, normal subjects
Lowe, Val J. , Weigand, Stephen D. , Senjem, Matthew L. , Vemuri, Prashanthi , Jordan, Lennon, Kantarci, Kejal , Petersen, Ronald C. , Boeve, Bradley F. , Jack, Clifford R. , Knopman, David S. , Vemuri, Prashanthi , Senjem, Matthew L , Kantarci, Kejal

Neurology | May 3, 2014 | Volume: 82 | Issue: 22 | Pages: 1959-1967

10.1212/wnl.0000000000000467 Get It

Past hormone therapy in older women
Kantarci, Kejal , Maki, Pauline M. , Kantarci, Kejal

Neurology | January 3, 2014 | Volume: 82 | Issue: 5 | Pages: 380-381

10.1212/wnl.0000000000000093 Get It

The Role of Diffusion Tensor Imaging in Detecting Microstructural Changes in Prodromal Alzheimer's Disease
Zhang, Bing , Zhu, Bin , Kantarci, Kejal , Xu, Yun , Kantarci, Kejal

CNS Neuroscience & Therapeutics | December 12, 2013 | Volume: 20 | Issue: 1 | Pages: 3-9

10.1111/cns.12166 Get It

SummaryThe MRI technique diffusion tensor imaging (DTI) is reviewed along with microstructural changes associated with prodromal Alzheimer's disease (AD) as a potential biomarker for clinical applications. The prodromal stage of AD is characterized by mild cognitive impairment (MCI), representing a transitional state between normal aging and AD. Microstructural abnormalities on DTI are promising in vivo biomarkers of gray and white matter changes associated with the progression of AD pathology. Elevated mean diffusivity and decreased fractional anisotropy are consistently found in prodromal AD, and even in cognitively normal elderly who progress to MCI. However, quality of parameter maps may be affected by artifacts of motion, susceptibility, and eddy current‐induced distortions. The DTI maps are typically analyzed by region‐of‐interest or voxel‐based analytic techniques such as tract‐based spatial statistics. DTI‐based index of diffusivity is complementary to macrostructural gray matter changes in the hippocampus in detecting prodromal AD. Breakdown of structural connectivity measured with DTI may impact cognitive performance during early AD. Furthermore, assessment of hippocampal connections may help in understanding the cerebral organization and remodeling associated with treatment response.